Application number | Title of the application | Filing Date | Status |
---|
Array
(
[id] => 17532253
[patent_doc_number] => 20220110862
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-14
[patent_title] => TREATMENT OF COGNITIVE DYSFUNCTION WITH PYRROLOPYRIDINE-ANILINE COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 17/483468
[patent_app_country] => US
[patent_app_date] => 2021-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21462
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17483468
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/483468 | TREATMENT OF COGNITIVE DYSFUNCTION WITH PYRROLOPYRIDINE-ANILINE COMPOUNDS | Sep 22, 2021 | Pending |
Array
(
[id] => 17334462
[patent_doc_number] => 20220000793
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-06
[patent_title] => BIOMASS-BASED ENCAPSULATING MATERIAL FOR PROTECTION OF PROBIOTIC ACTIVITY AND AN ENCAPSULATING METHOD
[patent_app_type] => utility
[patent_app_number] => 17/481263
[patent_app_country] => US
[patent_app_date] => 2021-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8559
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17481263
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/481263 | Biomass-based encapsulating material for protection of probiotic activity and an encapsulating method | Sep 20, 2021 | Issued |
Array
(
[id] => 18027711
[patent_doc_number] => 11510870
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2022-11-29
[patent_title] => Substrates for vaporizing and delivering an aerosol
[patent_app_type] => utility
[patent_app_number] => 17/463343
[patent_app_country] => US
[patent_app_date] => 2021-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 7
[patent_no_of_words] => 9843
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 104
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17463343
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/463343 | Substrates for vaporizing and delivering an aerosol | Aug 30, 2021 | Issued |
Array
(
[id] => 17426998
[patent_doc_number] => 20220054706
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-24
[patent_title] => SCAFFOLDS FROM SELF-ASSEMBLING TETRAPEPTIDES SUPPORT 3D SPREADING, OSTEOGENIC DIFFERENTIATION AND ANGIOGENESIS OF MESENCHYMAL STEM CELLS
[patent_app_type] => utility
[patent_app_number] => 17/401542
[patent_app_country] => US
[patent_app_date] => 2021-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14586
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17401542
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/401542 | SCAFFOLDS FROM SELF-ASSEMBLING TETRAPEPTIDES SUPPORT 3D SPREADING, OSTEOGENIC DIFFERENTIATION AND ANGIOGENESIS OF MESENCHYMAL STEM CELLS | Aug 12, 2021 | Pending |
Array
(
[id] => 17226993
[patent_doc_number] => 20210353549
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-18
[patent_title] => Mineral Coated Microparticles for Co-Delivery of Anti-Inflammatory Molecules with Nucleic Acids to Improve Gene Delivery Outcomes
[patent_app_type] => utility
[patent_app_number] => 17/379351
[patent_app_country] => US
[patent_app_date] => 2021-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7178
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -1
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17379351
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/379351 | Mineral coated microparticles for co-delivery of anti-inflammatory molecules with nucleic acids to improve gene delivery outcomes | Jul 18, 2021 | Issued |
Array
(
[id] => 17198727
[patent_doc_number] => 20210338821
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-04
[patent_title] => Hydrogel Compositions
[patent_app_type] => utility
[patent_app_number] => 17/372773
[patent_app_country] => US
[patent_app_date] => 2021-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4592
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17372773
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/372773 | Hydrogel Compositions | Jul 11, 2021 | Abandoned |
Array
(
[id] => 18075960
[patent_doc_number] => 20220401572
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-22
[patent_title] => POROUS SILICATE/MAGNETIC FERRITE NANOCARRIER FOR COMBINATION ANTI-CANCER THERAPEUTIC AND ANTIOXIDANT DELIVERY
[patent_app_type] => utility
[patent_app_number] => 17/351758
[patent_app_country] => US
[patent_app_date] => 2021-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16808
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17351758
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/351758 | Porous silicate/magnetic ferrite nanocarrier for combination anti-cancer therapeutic and antioxidant delivery | Jun 17, 2021 | Issued |
Array
(
[id] => 18075691
[patent_doc_number] => 20220401303
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-22
[patent_title] => Personalized Medicament Delivery Product
[patent_app_type] => utility
[patent_app_number] => 17/350356
[patent_app_country] => US
[patent_app_date] => 2021-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5761
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17350356
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/350356 | Personalized Medicament Delivery Product | Jun 16, 2021 | Abandoned |
Array
(
[id] => 18075759
[patent_doc_number] => 20220401371
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-22
[patent_title] => COMPARTMENTED HARD SHELL CAPSULE AND APPARATUS AND METHOD FOR FORMING, FILLING, AND ENCAPSULATING A COMPARTMENTED HARD SHELL CAPSULE
[patent_app_type] => utility
[patent_app_number] => 17/351190
[patent_app_country] => US
[patent_app_date] => 2021-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11581
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17351190
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/351190 | COMPARTMENTED HARD SHELL CAPSULE AND APPARATUS AND METHOD FOR FORMING, FILLING, AND ENCAPSULATING A COMPARTMENTED HARD SHELL CAPSULE | Jun 16, 2021 | Abandoned |
Array
(
[id] => 17272749
[patent_doc_number] => 20210378947
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-09
[patent_title] => Biodegradable Implant for Sustained Trans-Nasal Delivery of Therapeutic Agents to the Brain
[patent_app_type] => utility
[patent_app_number] => 17/338505
[patent_app_country] => US
[patent_app_date] => 2021-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17140
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17338505
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/338505 | Biodegradable Implant for Sustained Trans-Nasal Delivery of Therapeutic Agents to the Brain | Jun 2, 2021 | Pending |
Array
(
[id] => 17532509
[patent_doc_number] => 20220111118
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-14
[patent_title] => METHOD AND APPARATUS FOR TREATING BONE FRACTURES, AND/OR FOR FORTIFYING AND/OR AUGMENTING BONE, INCLUDING THE PROVISION AND USE OF COMPOSITE IMPLANTS, AND NOVEL COMPOSITE STRUCTURES WHICH MAY BE USED FOR MEDICAL AND NON-MEDICAL APPLICATIONS
[patent_app_type] => utility
[patent_app_number] => 17/338274
[patent_app_country] => US
[patent_app_date] => 2021-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 52850
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 122
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17338274
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/338274 | METHOD AND APPARATUS FOR TREATING BONE FRACTURES, AND/OR FOR FORTIFYING AND/OR AUGMENTING BONE, INCLUDING THE PROVISION AND USE OF COMPOSITE IMPLANTS, AND NOVEL COMPOSITE STRUCTURES WHICH MAY BE USED FOR MEDICAL AND NON-MEDICAL APPLICATIONS | Jun 2, 2021 | Abandoned |
Array
(
[id] => 18573666
[patent_doc_number] => 11730167
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-08-22
[patent_title] => Triamine solidification using diacids
[patent_app_type] => utility
[patent_app_number] => 17/303573
[patent_app_country] => US
[patent_app_date] => 2021-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13800
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 150
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17303573
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/303573 | Triamine solidification using diacids | Jun 1, 2021 | Issued |
Array
(
[id] => 17049814
[patent_doc_number] => 20210259248
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-26
[patent_title] => LIQUID COMPOSITION COMPRISING MEFENTRIFLUCONAZOLE
[patent_app_type] => utility
[patent_app_number] => 17/319417
[patent_app_country] => US
[patent_app_date] => 2021-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3227
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -1
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17319417
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/319417 | Liquid composition comprising mefentrifluconazole | May 12, 2021 | Issued |
Array
(
[id] => 18869889
[patent_doc_number] => 11857669
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-01-02
[patent_title] => Treatment of a disease of the gastrointestinal tract with a JAK inhibitor and devices
[patent_app_type] => utility
[patent_app_number] => 17/313339
[patent_app_country] => US
[patent_app_date] => 2021-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 56
[patent_figures_cnt] => 84
[patent_no_of_words] => 135692
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 134
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17313339
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/313339 | Treatment of a disease of the gastrointestinal tract with a JAK inhibitor and devices | May 5, 2021 | Issued |
Array
(
[id] => 17020790
[patent_doc_number] => 20210244661
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-12
[patent_title] => METHOD OF TREATING EPILEPSY
[patent_app_type] => utility
[patent_app_number] => 17/244963
[patent_app_country] => US
[patent_app_date] => 2021-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7699
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17244963
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/244963 | Method of treating epilepsy | Apr 29, 2021 | Issued |
Array
(
[id] => 17183972
[patent_doc_number] => 20210330857
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-28
[patent_title] => ANTIMICROBIAL ADHESIVE COPOLYMER COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 17/242241
[patent_app_country] => US
[patent_app_date] => 2021-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6479
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17242241
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/242241 | ANTIMICROBIAL ADHESIVE COPOLYMER COMPOSITIONS | Apr 26, 2021 | Pending |
Array
(
[id] => 17988918
[patent_doc_number] => 20220354955
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-10
[patent_title] => SUSTAINED DELIVERY FORMULATIONS OF RISPERIDONE COMPOUND
[patent_app_type] => utility
[patent_app_number] => 17/237207
[patent_app_country] => US
[patent_app_date] => 2021-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42872
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17237207
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/237207 | Sustained delivery formulations of risperidone compound | Apr 21, 2021 | Issued |
Array
(
[id] => 17140060
[patent_doc_number] => 20210308071
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-07
[patent_title] => Treatment method to abort and or reduce the severity of upper respiratory viral illness as well as to prevent upper respiratory viral illness in humans
[patent_app_type] => utility
[patent_app_number] => 17/221838
[patent_app_country] => US
[patent_app_date] => 2021-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3759
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17221838
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/221838 | Treatment method to abort and or reduce the severity of upper respiratory viral illness as well as to prevent upper respiratory viral illness in humans | Apr 3, 2021 | Abandoned |
Array
(
[id] => 16976289
[patent_doc_number] => 20210220526
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-22
[patent_title] => BIODEGRADABLE SILK EAR TUBES
[patent_app_type] => utility
[patent_app_number] => 17/220914
[patent_app_country] => US
[patent_app_date] => 2021-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9463
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17220914
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/220914 | Biodegradable silk ear tubes | Mar 31, 2021 | Issued |
Array
(
[id] => 16961632
[patent_doc_number] => 20210213131
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-15
[patent_title] => TREATMENT FOR REDUCING ADVERSE EVENTS INCLUDING CHEMOTHERAPY DISCOMFORT AND OTHER CONDITIONS
[patent_app_type] => utility
[patent_app_number] => 17/219701
[patent_app_country] => US
[patent_app_date] => 2021-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9198
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17219701
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/219701 | Treatment for reducing adverse events including chemotherapy discomfort and other conditions | Mar 30, 2021 | Issued |